This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Theragenics' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Theragenics Corporation ( TGX)

Q4 2011 Earnings Call

February 23, 2012 11:00 am ET


Christine Jacobs - Chairman and CEO

Frank Tarallo - CFO


Joe Munda - Sidoti & Company

Ezekiel Kruglick - Ardent Research

Jeff Anderson - Encore Group



Greetings and welcome to the Theragenics' fourth quarter and yearend 2011 earnings conference call. It is now my pleasure to introduce, Ms. Christine Jacobs, Chairman and CEO of Theragenics.

Christine Jacobs

Good morning and welcome to Theragenics' fourth quarter and yearend 2011 conference call. Thank you for joining us today. In just a few minutes, I'll provide comments on the past quarter and 2011 and a little about the outlook for 2012. I will also talk about our just announced acquisition of the Core Oncology prostate brachytherapy customers, but first I am going to turn the call over to Frank Tarallo, our Chief Financial Officer, he's going to provide a review of the financials.

Frank Tarallo

Thank you, Chris. This morning we released our consolidated financial results for the fourth quarter and yearend 2011. If you did not receive this news release or if you would like to be added to either our fax or email distribution list, please contact Investor Relations at 800-998-8479, or 770-271-0233.

Before I begin my review, please be aware that some comments made during this conference call may contain forward-looking statements involving risks and uncertainties regarding our operations and future results. Please see our press release issued today and our filings with the Securities and Exchange Commission, including without limitation, the company's Form 10-K and Forms 10-Q, which identifies specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,812.19 +19.51 0.11%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs